As shown in Figure 5, compared with the sham group, the expression of p-AKT, p-ERK1/2 and p-JNK in the TAC group was increased significantly, while after treatment, the expression decreased markedly. The gene discussed is MAPK3; the disease is persistent truncus arteriosus.